COVID-19

Latest News


CME Content


 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards

John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks on the institution's response and workflow adjustments made amid the coronavirus pandemic, how virtual appointments have helped in working through a backlog of patients, and whether cancer may be the next big crisis in the UK due to missed diagnoses during the lockdown.

rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion on how having a solid financial plan in place can ease anxiety amid the pandemic, their advice to ophthalmologists contemplating retirement, as well as the uncertainty surrounding the economy ahead of the 2020 election, ongoing virus, and the unknown of what's in store for 2021.

John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a possible second wave, as well as the potential financial repercussions the economy may face.

Physicians struggling under the strains of the pandemic often think they cannot seek professional counseling, as burnout is at an all-time high and more than 50% of ophthalmologists saw their incomes drop by more than 50%.

Humoral immunity against SARS-CoV-2 may not last long in individuals who had mild infections, and the loss of antibodies may actually be quicker than reported previously for the virus, according to investigators from the David Geffen School of Medicine, University of California, Los Angeles.

Capabilities of telemedicine during a pandemic: Part II

Ranya Habash, MD, medical director, Technology Innovation, Bascom Palmer Eye Institute, University of Miami, speaks on what she wished she’d known about telemedicine in ophthalmology five years ago, the impact of the pandemic in regards to FDA regulations, as well as why the future of telemedicine requires a new way of thinking.

COVID-19 pandemic driving jump in Medicaid enrollment

According to an analysis of Medicaid enrollment data during the coronavirus disease 2019 (COVID-19) pandemic, there has been an increase in enrollment during the crisis. This shift is likely to have a ripple effect throughout the healthcare landscape, including ophthalmology.